The initiation of coverage by a reputable analyst with a positive Outperform rating and a significant price target suggests a strong bullish outlook for Q32 Bio. This is likely to attract investor attention and could lead to a short-term increase in the stock price, as market participants often react positively to such analyst coverage and targets.